A New PRECiSe (Priming Reduced Extracorporeal Circulation Setup) Minimizes the Need for Blood Transfusions: First Clinical Results in Coronary Artery Bypass Grafting
AbstractHemodilution by the crystalloid priming volume of standard heart-lung machines in cardiac surgery is associated with impaired organ function and increased blood transfusion requirements. The aim of this study was to evaluate the effect of the use of the newly developed priming reduced extracorporeal circulation setup (PRECiSe) on perioperative hemodilution and transfusion requirements. In a matched prospective study, 40 patients who underwent operations with the PRECiSe in elective primary coronary artery bypass surgery were compared with 40 patients who underwent operations with the standard heart-lung machine. A significant reduction in final priming volume resulted in a significantly reduced degree of hemodilution and transfusion requirements during and after extracorporeal circulation. In the PRECiSe group, only 10% of the patients needed transfusions during their hospital stay, whereas 35% of the patients in the control group required any transfusion (P < .05). The average transfusion per patient was 0.16 units in the PRECiSe group and 1.25 units in the control group (P < .05). The PRECiSe was demonstrated to be safe and effective in coronary artery bypass surgery with respect to transfusion requirements and hemodilution, as well as with regard to patient safety, as represented by perioperative myocardial performance.
Beholz S, Kessler M, Thölke R, Konertz W. 2003. PRECiSe (priming reduced extracorporeal circulation setup) with the DeltaStream diagonal pump. Artif Organs 27:1110-5.nBeholz S, Koch C, Konertz W. 2003. Quality management system of a university cardiac surgery department according to DIN EN ISO 9001: 2000. Thorac Cardiovasc Surg 51:167-73.nBeholz S, Konertz W. 2002. Minimally invasive coronary revascularization: current status and outlook to the future [in German]. Chirurgische Praxis 60:687-700.nBenetti FJ, Geffner L, Naselli G, Wood M. 1991. Direct myocardial revascularization without extracorporeal circulation: experience in 700 patients. Chest 100:312-6.nCalafiore AM, Teodori G, Mezzetti A, et al. 1995. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 59:398-402.nDietrich W, Lüth JU, Kormann J, et al. 1999. Intraoperative blood requirements and allogeneic blood transfusion in cardioanesthesia: data analysis of 7729 patients in 12 cardiac surgical clinics [in German]. Anaesthesist 48:876-83.nFang WC, Helm RE, Krieger KH, et al. 1997. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 96:II-194-9.nFolliguet TA, Villa E, Vandeneyden F, Laborde F. 2003. Coronary artery bypass graft with minimal extracorporeal circulation. Heart Surg Forum 6:297-301.nFromes Y, Gaillard D, Ponzio O, et al. 2002. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22:527-33.nGibbon JH Jr. 1954. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 37:171-85.nGravlee GP, Davis RF, Kurusz M, Utley JR, eds. 2000. Cardiopulmonary bypass. Philadelphia, Pa: Lippincott Williams & Wilkins. Hardy JF, Martineau R, Couturier A, Belisle S, Cartier R, Carrier M. 1998. Influence of haemoglobin concentration after extracorporeal circulation on mortality and morbidity in patients undergoing cardiac surgery. Br J Anaesth 81(suppl 1):38-45.nKalmar P, Irrgang E; German Society for Thoracic and Cardiovascular Surgery. 2003. Cardiac surgery in Germany during 2002: a report by German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 51:25-9.nMack MJ. 2003. Advances in the treatment of coronary artery disease. Ann Thorac Surg 76:S2240-5.nNollert G, Sperling J, Sakamoto T, Jaeger BR, Jonas RA. 2001. Higher hematocrit improves liver blood flow and metabolism during cardiopulmonary bypass in piglets. Thorac Cardiovasc Surg 49:226-30.nRoques F, Nashef SAM, Gauducheau E, et al. 1999. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816-23.nSwaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M. 2003. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 76:784-91.nBeholz S, Kessler M, Thölke R, Konertz W. 2003. PRECiSe (priming reduced extracorporeal circulation setup): results of a safety study. Heart Surg Forum 6:311-5.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).